Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Fostemsavir
Locations
1
Canada
CR CHUM
Montreal, Quebec, Canada
Start Date
September 30, 2025
Primary Completion Date
October 1, 2028
Completion Date
January 1, 2029
Last Updated
November 19, 2025
NCT06598397
NCT07113223
NCT07071623
NCT04375800
NCT07209917
NCT06886971
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions